Search Results - "MATSUMOTO, SATOHIRO"

Refine Results
  1. 1

    Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease by Matsumoto, Satohiro, Mashima, Hirosato

    Published in Scientific reports (17-12-2020)
    “…Mesalazine is a key drug used for remission induction and maintenance therapy in inflammatory bowel disease (IBD). We sometimes encounter patients who develop…”
    Get full text
    Journal Article
  2. 2

    Selection of appropriate endoscopic therapies for duodenal tumors: An open-label study, single-center experience by Matsumoto, Satohiro, Yoshida, Yukio

    Published in World journal of gastroenterology : WJG (14-07-2014)
    “…AIM:To determine an appropriate compartmentalization of endoscopic submucosal dissection(ESD)or endoscopic mucosal resection(EMR)for duodenal…”
    Get full text
    Journal Article
  3. 3

    The efficacy of endoscopic submucosal dissection for colorectal tumors extending to the dentate line by Matsumoto, Satohiro, Mashima, Hirosato

    “…Purpose Although endoscopic submucosal dissection (ESD) is becoming the mainstay of the treatment strategies, rather than surgical treatment, for colorectal…”
    Get full text
    Journal Article
  4. 4

    Construction of a preoperative scoring system to predict the difficulty level of colorectal endoscopic submucosal dissection by Matsumoto, Satohiro, Uehara, Takeshi, Mashima, Hirosato

    Published in PloS one (27-06-2019)
    “…We attempted to examine the factors contributing to the difficulty in performance of colorectal ESD, with the aim of constructing a scoring system that could…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Usefulness of the Optimal Cutoff Value and Delta Value of Leucine-Rich Alpha 2 Glycoprotein in Ulcerative Colitis by Matsumoto, Satohiro, Mashima, Hirosato

    Published in Crohn's & colitis 360 (01-10-2022)
    “…Leucine-rich alpha 2 glycoprotein (LRG) is a novel serum biomarker used to determine disease activity in inflammatory bowel disease. We investigated the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Post-ERCP biliary complications in patients with biliary type sphincter of Oddi dysfunction by Miyatani, Hiroyuki, Mashima, Hirosato, Sekine, Masanari, Matsumoto, Satohiro

    Published in Scientific reports (02-07-2018)
    “…Sphincter of Oddi dysfunction (SOD) has a high risk of post-ERCP pancreatitis. Cholangitis, colicky pain, and jaundice from cholestasis also occur after ERCP…”
    Get full text
    Journal Article
  10. 10

    Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies by Otake, Haruka, Matsumoto, Satohiro, Mashima, Hirosato

    Published in Intestinal research (01-10-2022)
    “…Background/Aims: Although anti-tumor necrosis factor (TNF)-α agents are important therapeutic drugs for Crohn’s disease (CD), data regarding their long-term…”
    Get full text
    Journal Article
  11. 11

    Crohn's Disease with Mesalazine Allergy that Was Difficult to Differentiate from Comorbid Ulcerative Colitis by Tsuboi, Rumiko, Matsumoto, Satohiro, Miyatani, Hiroyuki, Mashima, Hirosato

    Published in Internal Medicine (01-03-2019)
    “…An 18-year-old man diagnosed with ileocolonic Crohn's disease with circumferential strictures of the ascending colon started treatment with mesalazine and…”
    Get full text
    Journal Article
  12. 12

    Efficacy of endoscopic screening in an isolated island: A case–control study by Matsumoto, Satohiro, Yoshida, Yukio

    Published in Indian journal of gastroenterology (01-01-2014)
    “…Although endoscopic screening has become more common in recent years, its efficacy in reducing the mortality from gastric cancer has not yet been demonstrated…”
    Get full text
    Journal Article
  13. 13

    Clinical features and management of painless biliary type sphincter of Oddi dysfunction by Miyatani, Hiroyuki, Mashima, Hirosato, Sekine, Masanari, Matsumoto, Satohiro

    Published in Journal of international medical research (01-07-2019)
    “…Objective The objective of this study was to clarify the characteristics and management of painless biliary type sphincter of Oddi dysfunction (SOD). Methods…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Late-onset Wilson Disease in a Patient Followed-up for Nonalcoholic Fatty Liver Disease by Asano, Takeharu, Yoshikawa, Shuhei, Matsumoto, Keita, Kashima, Hitomi, Koito, Yudai, Miura, Takaya, Takahashi, Yuko, Tsuboi, Rumiko, Ishii, Takehiro, Otake, Haruka, Uehara, Takeshi, Sekine, Masanari, Matsumoto, Satohiro, Asabe, Shinichi, Miyatani, Hiroyuki, Mashima, Hirosato

    Published in Internal Medicine (01-01-2024)
    “…A 73-year-old woman was referred to our hospital for persistent liver dysfunction. When the patient was 45 years old, her youngest sister had been diagnosed…”
    Get full text
    Journal Article
  16. 16
  17. 17

    C‐reactive protein predicts the development of walled‐off necrosis in patients with severe acute pancreatitis by Fujiwara, Junichi, Matsumoto, Satohiro, Sekine, Masanari, Mashima, Hirosato

    Published in JGH open (01-08-2021)
    “…Background and Aim Walled‐off necrosis (WON) is reported to occur in 1–9% of patients with acute pancreatitis. However, the factors associated with the onset…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Relationship between human herpesvirus 6 infection and inflammatory bowel disease using novel biomarker by Matsumoto, Satohiro, Otaki, Yuzo, Yoshida, Yukio, Kobayashi, Nobuyuki, Oka, Naomi, Yanagisawa, Hiroyuki, Kondo, Kazuhiro

    Published in JGH open (01-11-2023)
    “…Objective Inflammatory bowel disease (IBD) is closely related to stress and fatigue. Human herpesvirus 6B (HHV‐6B) is reactivated by stress and fatigue and is…”
    Get full text
    Journal Article
  20. 20